Cargando…

Convalescent plasma for SARS-CoV-2 infection: win or learn

Current evidence does not support the use of convalescent plasma in the standard therapy for COVID-19 https://bit.ly/3DGyz6t

Detalles Bibliográficos
Autores principales:	Contreras-Barbeta, Enric, Millan, Anna, Rello, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462013/ https://www.ncbi.nlm.nih.gov/pubmed/34531275 http://dx.doi.org/10.1183/13993003.02076-2021

Ejemplares similares

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
por: Natarajan, Harini, et al.
Publicado: (2021)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
por: Jungbauer, Christof, et al.
Publicado: (2020)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma: Ecchymosis: case report
Publicado: (2022)

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin
por: Volk, Andreas, et al.
Publicado: (2021)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
por: Moubarak, Mohamed, et al.
Publicado: (2021)

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
por: Wouters, Elise, et al.
Publicado: (2023)

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
por: Tonn, Torsten, et al.
Publicado: (2020)

Convalescent anti-SARS-CoV-2 plasma: Organising pneumonia: case report
Publicado: (2020)

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
por: Dulipsingh, Latha, et al.
Publicado: (2020)

Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
por: Sullivan, H. Cliff, et al.
Publicado: (2020)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Investigation of SARS-CoV-2 RNAemia in the convalescent plasma of COVID-19 patients
por: Perumal, N., et al.
Publicado: (2022)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Convalescent Plasma – Is it Useful for Treating SARS Co-V2 infection?
por: Ranganathan, Sudha, et al.
Publicado: (2020)

Plasma from donors convalescent from SARS-CoV-2 infection–A matter of priorities
por: Farrugia, A.
Publicado: (2020)

Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2021)

Management of hypoxemia in SARS-CoV-2 infection: Lessons learned from one year of experience, with a special focus on silent hypoxemia
por: Serrano, Ricardo, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma
por: Wang, Yingdan, et al.
Publicado: (2022)

Detection of SARS‐CoV‐2‐independent immunoregulatory activity of COVID‐19 convalescent plasma
por: Brox, Regine, et al.
Publicado: (2021)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
por: Davis, Samantha K, et al.
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/immunosuppressants: SARS-CoV-2 infection, its re-infection and off label use: case report
Publicado: (2021)

Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
por: Tzou, Philip L., et al.
Publicado: (2022)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent Plasma
por: Deere, Jesse D., et al.
Publicado: (2021)

Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
por: Fodor, Eszter, et al.
Publicado: (2022)

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
por: Rello, Jordi, et al.
Publicado: (2020)

SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
por: Balashov, Dmitry, et al.
Publicado: (2021)

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals
por: Robbiani, Davide F., et al.
Publicado: (2020)

Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

Convalescent-anti-SARS-CoV-2-plasma: Anaphylactic shock and transfusion reaction: case report
Publicado: (2020)

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
por: Benner, Sarah E, et al.
Publicado: (2020)

559. Outcomes of Convalescent Plasma Transfusion for SARS-CoV2 Patients in the Intensive Care Unit
por: Khalid, Rabeeya, et al.
Publicado: (2020)

Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome
por: Diorio, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hsg7812iaksoo2j0bso8g3ogq3